[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355794-105":59,"doc-detail-355794-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","bioinspired-polymer-incorporated-copperiron-nanozyme-to-boost-cascade-ros-accumulation-for-augmented-hepatocellular-carcinoma-cuproptosisferroptosis","Bioinspired polymer-incorporated copper/iron nanozyme to boost cascade ROS accumulation for augmented hepatocellular carcinoma cuproptosis/ferroptosis","","Hepatocellular carcinoma is a highly lethal tumor with limited curative options, and its progression is strongly supported by the glutathione (GSH) antioxidant defense system. A gelatin (GT)/hyaluronic acid (HA)-stabilized Copper (Cu) and Iron (Fe) nanoparticle platform (5CFGH NPs) is proposed to trigger self-amplified dual cuproptosis and ferroptosis. HA selectively binds CD44-overexpressing HCC cells, enabling acidic, receptor-mediated release of Cu and Fe ions. Released Fe3+ and Cu2+ disrupt GSH and drive Fenton-like ROS generation via H2O2 depletion. When H2O2 is consumed, elevated Cu+ promotes lipoylated protein aggregation to intensify cuproptosis, yielding strong HCC cytotoxicity.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/bioinspired-polymer-incorporated-copperiron-nanozyme-to-boost-cascade-ros-accumulation-for-augmented-hepatocellular-carcinoma-cuproptosisferroptosis/355794/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/bioinspired-polymer-incorporated-copperiron-nanozyme-to-boost-cascade-ros-accumulation-for-augmented-hepatocellular-carcinoma-cuproptosisferroptosis/355794.png","ImageObject",300,407,{"name":92,"@type":93},"Stanford","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",15,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main therapeutic concept of the 5CFGH nanoparticle system?","Question",{"text":113,"@type":114},"5CFGH is designed to induce a self-amplified dual mechanism of cuproptosis and ferroptosis. It uses Cu/Fe ion release to disrupt the GSH antioxidant system and drive ROS generation, then leverages Cu+ to promote lipoylated protein aggregation for cuproptosis intensification.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does the delivery system selectively target hepatocellular carcinoma cells?",{"text":118,"@type":114},"HA in 5CFGH selectively binds to HCC cells overexpressing the CD44 receptor. After receptor-mediated endocytosis, the particles release metal ions under acidic intracellular conditions.",{"name":120,"@type":111,"acceptedAnswer":121},"How do ferroptosis and cuproptosis amplify within the proposed mechanism?",{"text":122,"@type":114},"Released Fe3+ and Cu2+ react with GSH, converting it and damaging the antioxidant defense, while H2O2 is used in Fenton/Fenton-like reactions to produce harmful •OH. When H2O2 becomes depleted, increased Cu+ levels promote aggregation of lipoylated proteins, which strengthens cuproptosis, forming a cascade.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},355794,1790183355,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":14,"preview_urls":146},2336477552062,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Journal of Materials Science: Materials in Medicine (2026)37:68  \n[https://doi.org/10.1007/s10856-026-07045-y](https://doi.org/10.1007/s10856-026-07045-y)  \nDELIVERY SYSTEMS  \nOriginal Research  \nBioinspired polymer-incorporated copper/iron nanozyme to boost cascade ROS accumulation for augmented hepatocellular carcinoma cuproptosis/ferroptosis  \nSheng Zhang1 ● Xiaomei Liu2 ● Longxin Fan3 ● Hongtao Luo4 ● Haiyun Zhang5 ● Bing Zhou1  \nReceived: 8 January 2026 / Accepted: 27 March 2026 © The Author(s) 2026  \nAbstract  \nHepatocellular carcinoma (HCC), an infamously incurable tumor, is extremely sensitive to ferroptosis, and its development is greatly aided by the glutathione (GSH) antioxidant defense system. We present a gelatin (GT)/hyaluronic acid (HA) -stabilized Copper (Cu) and Iron (Fe) nanoparticle (5CFGH NPs) for HCC therapy that uses a self-ampliﬁed dual mechanism of cuproptosis and ferroptosis. It has a Cu/Fe mass ratio of 5:5. HA in 5CFGH selectively binds to HCC cells overexpressing CD44 receptor. This enables 5CFGH to release metal ions in acidic conditions after entering cells through receptor-mediated endocytosis. In the HepG2 cell line, released Fe3+ and Cu2+ react with GSH to form Fe2+ and Cu+, thereby damaging the antioxidant system. To promote ferroptosis, these ions react with H2O2 in Fenton/Fenton-like ways, producing harmful hydroxyl radicals (•OH) . High-valent Fe3+ and Cu2+ are created in the meantime, creating a cycle that depletes GSH and generates •OH. When H2O2 is depleted, the cells’ increased Cu+ level leads to the aggregation of lipoylated proteins, which intensiﬁes cuproptosis. 5CFGH showed excellent cell-killing efﬁciency against HCC. Overall, 5CFGH is a possible drug that could induce self-ampliﬁcation of cuproptosis/ferroptosis in HCC.  \nGraphical Abstract  \n* Bing Zhou [zhoubing007008@126.com](zhoubing007008@126.com)  \n1 Department of Hepatobiliary Pancreatic Splenic Surgery, The First Afﬁliated Hospital of Xinxiang Medical University, Weihui City, Henan Province, China  \n2 Department of Radiation Therapy Ward II, The First Afﬁliated Hospital of Xinxiang Medical University, Weihui City, Henan Province, China  \n3 Department of General Surgery Ward II, The First Afﬁliated Hospital of Xinxiang Medical College, Weihui City, Henan Province, China  \n4 Department of Colorectal and Anal Surgery, The First Afﬁliated Hospital of Xinxiang Medical University, Weihui City, Henan Province, China  \n5 Department of Gastroenterology Ward III, The First Afﬁliated Hospital of Xinxiang Medical University, Weihui City, Henan Province, China  \n1 Introduction  \nLiver cancer has become the third major cause of cancerrelated fatalities globally. HCC is the typical kind of liver cancer, accounting for nearly 80% of all occurrences [1] . Treatment modalities for patients diagnosed with early-stage HCC encompass surgical resection, liver transplantation, and drug therapy [2] . Regrettably, maximum patients are diagnosed at a progressive stage, presenting a considerable obstacle to worldwide health initiatives. Despite radical surgery being a successful strategy, its efﬁcacy has signiﬁcantly declined over time, leading to a ﬁve-year survival ratio of under 20%[3] . Traditional chemotherapy drugs like paclitaxel and cisplatin demonstrate restricted efﬁcacy against HCC. Moreover, FDA-approved chemotherapeutics such as lenvatinib and sorafenib face limitations in treating HCC due to acquired resistance [4] . Thus, the identiﬁcation of novel and effective techniques for HCC treatment has emerged as a paramount goal. HCC continues to exhibit severe morbidity and low survival rates, necessitating the investigation of effective pharmacological agents that might target cell death pathways. Ferroptosis is an Fe-dependent mechanism of programmed cell death characterized by heightened oxidative stress and lipid peroxidation (LPO) of the cell membranes, leading to compromised plasma membrane integrity and, ultimately, cell death [5] . ","cbCaisVBnJpAcgsj","https://ap.wps.com/l/cbCaisVBnJpAcgsj","pdf",4083409,"English","# Abstract\n## Introduction\n## Delivery Systems\n## Graphical Abstract","[{\"question\":\"What is the main therapeutic concept of the 5CFGH nanoparticle system?\",\"answer\":\"5CFGH is designed to induce a self-amplified dual mechanism of cuproptosis and ferroptosis. It uses Cu/Fe ion release to disrupt the GSH antioxidant system and drive ROS generation, then leverages Cu+ to promote lipoylated protein aggregation for cuproptosis intensification.\"},{\"question\":\"How does the delivery system selectively target hepatocellular carcinoma cells?\",\"answer\":\"HA in 5CFGH selectively binds to HCC cells overexpressing the CD44 receptor. After receptor-mediated endocytosis, the particles release metal ions under acidic intracellular conditions.\"},{\"question\":\"How do ferroptosis and cuproptosis amplify within the proposed mechanism?\",\"answer\":\"Released Fe3+ and Cu2+ react with GSH, converting it and damaging the antioxidant defense, while H2O2 is used in Fenton/Fenton-like reactions to produce harmful •OH. When H2O2 becomes depleted, increased Cu+ levels promote aggregation of lipoylated proteins, which strengthens cuproptosis, forming a cascade.\"}]","Bioinspired polymer-incorporated copper/iron nanozyme to boost cascade ROS accumulation for augmented hepatocellular carcinoma cuproptosis/ferroptosis | PDF",1790120994,38,[147,151],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/9b63d6e8feb9c9ce5e868f3bfd255dea.webp",983,1306,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/d0e5c87b8027e2cd07acb6cf9359e3fb.webp",982,1304]